IPG-11406

N/A

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameIPG-11406
Drug Alias NameIPG11406IPG-11406
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor antagonists
TargetsG-protein coupled receptor
Therapy Area/IndicationsLupus Erythematosus, SystemicLupus NephritisMultiple Sclerosis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesNanjing Immunophage Biotech Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNanjing Immunophage Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, SystemicLupus NephritisMultiple Sclerosis +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A